{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:15:17Z","timestamp":1780067717900,"version":"3.54.0"},"reference-count":13,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2019,3,30]]},"DOI":"10.1536\/ihj.19-039","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T22:45:14Z","timestamp":1553035514000},"page":"238-240","source":"Crossref","is-referenced-by-count":7,"title":["Endothelin-1 and Atrial Cardiomyopathy"],"prefix":"10.1536","volume":"60","author":[{"given":"Takumi J","family":"Matsubara","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhito","family":"Fujiu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"},{"name":"Department of Advanced Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Zegkos T, Efthimiadis GK, Parcharidou DG, <i>et al<\/i>. Atrial fibrillation in hypertrophic cardiomyopathy: A turning point towards increased morbidity and mortality. Hellenic J Cardiol 2017; 58: 331-9.","DOI":"10.1016\/j.hjc.2017.01.027"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Patten M, Pecha S, Aydin A. Atrial fibrillation in hypertrophic cardiomyopathy: Diagnosis and considerations for management. J Atr Fibrillation 2018; 10: 1556.","DOI":"10.4022\/jafib.1556"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Liu L, Wu L, Zheng L, <i>et al<\/i>. Associations between multiple circulating biomarkers and the presence of atrial fibrillation in hypertrophic cardiomyopathy with or without left ventricular outflow tract obstruction. Int Heart J 2019; 60: 327-35.","DOI":"10.1536\/ihj.18-438"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hathaway CK, Grant R, Hagaman JR, <i>et al<\/i>. Endothelin-1 critically influences cardiac function via superoxide-MMP9 cascade. Proc Natl Acad Sci U S A 2015; 112: 5141-6.","DOI":"10.1073\/pnas.1504557112"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Shubeita HE, McDonough PM, Harris AN, <i>et al<\/i>. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy. J Biol Chem 1990; 265: 20555-62.","DOI":"10.1016\/S0021-9258(17)30538-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mayyas F, Niebauer M, Zurick A, <i>et al<\/i>. Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease. Circ Arrhythm Electrophysiol 2010; 3: 369-79.","DOI":"10.1161\/CIRCEP.109.924985"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kocksk\u00e4mper J, Seidlmayer L, Walther S, Hellenkamp K, Maier LS, Pieske B. Endothelin-1 enhances nuclear Ca2+ transients in atrial myocytes through Ins (1,4,5) P3-dependent Ca2+ release from perinuclear Ca2+ stores. J Cell Sci 2008; 121: 186-95.","DOI":"10.1242\/jcs.021386"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Allessie MA. Atrial fibrillation-induced electrical remodeling in humans: what is the next step? Cardiovasc Res 1999; 44: 10-2.","DOI":"10.1016\/S0008-6363(99)00244-8"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Mueller EE, Momen A, Mass\u00e9 S, <i>et al<\/i>. Electrical remodelling precedes heart failure in an endothelin-1-induced model of cardiomyopathy. Cardiovasc Res 2011; 89: 623-33.","DOI":"10.1093\/cvr\/cvq351"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sabbah HN. Apoptotic cell death in heart failure. Cardiovasc Res 2000; 45: 704-12.","DOI":"10.1016\/S0008-6363(99)00348-X"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Dzeshka MS, Lip GY, Snezhitskiy V, Shantsila E. Cardiac fibrosis in patients with atrial fibrillation: Mechanisms and clinical implications. J Am Coll Cardiol 2015; 66: 943-59.","DOI":"10.1016\/j.jacc.2015.06.1313"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Guichard JB, Nattel S. Atrial cardiomyopathy: A useful notion in cardiac disease management or a passing fad? J Am Coll Cardiol 2017; 70: 756-65.","DOI":"10.1016\/j.jacc.2017.06.033"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Schneider JG, Tilly N, Hierl T, <i>et al<\/i>. Elevated plasma endothelin-1 levels in diabetes mellitus. Am J Hypertens 2002; 15: 967-72.","DOI":"10.1016\/S0895-7061(02)03060-1"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/60\/2\/60_19-039\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:38:50Z","timestamp":1663115930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/60\/2\/60_19-039\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,30]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.19-039","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,30]]}}}